Prometheus 2.0 engineering manufacturable humanized antibodies from diverse species

24 Apr 2026

Explore Prometheus 2.0™, an expanded antibody humanization platform designed to generate highly manufacturable humanized antibodies from diverse non‑murine sources, including rabbit and camelid antibodies. Using bioinformatic analysis and optimized human framework selection, the approach preserves antibody activity while improving expression and aggregation profiles, supporting the development of next‑generation biotherapeutics derived from structurally diverse antibody formats.

Links

Tags

Engineered AntibodiesEngineered antibodies are modified to enhance specificity, stability, and functionality for therapeutic and diagnostic applications. These antibodies are central to immunotherapy and biomarker detection. Compare engineered antibody solutions in our directory to find top products and reviews.BiotherapeuticsBiotherapeutics are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or in in vivo diagnostics. The most well-known example of a biotherapeutic product, and the first to be approved for therapeutic use, was recombinant human insulin.Protein EngineeringBioinformaticsBioinformatics uses computational models and methodologies to study biological processes and to understand biological data.
Prometheus 2.0 for manufacturable humanized antibodies - SelectScience resources